CN108562738A - 一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 - Google Patents
一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 Download PDFInfo
- Publication number
- CN108562738A CN108562738A CN201810323247.5A CN201810323247A CN108562738A CN 108562738 A CN108562738 A CN 108562738A CN 201810323247 A CN201810323247 A CN 201810323247A CN 108562738 A CN108562738 A CN 108562738A
- Authority
- CN
- China
- Prior art keywords
- nanofe
- solution
- aunps
- mgce
- immunosensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004020 luminiscence type Methods 0.000 title claims abstract description 58
- 238000001514 detection method Methods 0.000 title claims abstract description 37
- 108090000246 Histone acetyltransferases Proteins 0.000 title claims abstract description 36
- 102000003893 Histone acetyltransferases Human genes 0.000 title claims abstract description 36
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 23
- 238000001548 drop coating Methods 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 230000009871 nonspecific binding Effects 0.000 claims abstract description 6
- 230000002194 synthesizing effect Effects 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 86
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 claims description 54
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 claims description 54
- 101000978776 Mus musculus Neurogenic locus notch homolog protein 1 Proteins 0.000 claims description 50
- 238000003786 synthesis reaction Methods 0.000 claims description 33
- 230000015572 biosynthetic process Effects 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 20
- 108020004414 DNA Proteins 0.000 claims description 18
- -1 iron ion Chemical class 0.000 claims description 17
- 230000005389 magnetism Effects 0.000 claims description 15
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 14
- 239000003643 water by type Substances 0.000 claims description 14
- 239000011259 mixed solution Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- 239000007983 Tris buffer Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000007792 addition Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 6
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims description 6
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 6
- 229910021397 glassy carbon Inorganic materials 0.000 claims description 6
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims description 5
- 108010088751 Albumins Proteins 0.000 claims description 5
- 102000009027 Albumins Human genes 0.000 claims description 5
- 101150018489 DNA-C gene Proteins 0.000 claims description 5
- 229910004042 HAuCl4 Inorganic materials 0.000 claims description 5
- 239000012888 bovine serum Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 238000005253 cladding Methods 0.000 claims description 5
- 230000009514 concussion Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 claims description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 5
- 150000003003 phosphines Chemical class 0.000 claims description 5
- 238000001524 potential step chrono-amperometry Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 230000005518 electrochemistry Effects 0.000 claims description 4
- 238000003018 immunoassay Methods 0.000 claims description 4
- 239000000908 ammonium hydroxide Substances 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 101710155878 Histone acetyltransferase p300 Proteins 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- HRHBQGBPZWNGHV-UHFFFAOYSA-N azane;bromomethane Chemical compound N.BrC HRHBQGBPZWNGHV-UHFFFAOYSA-N 0.000 claims 1
- 229910002804 graphite Inorganic materials 0.000 claims 1
- 239000010439 graphite Substances 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- 230000035945 sensitivity Effects 0.000 description 11
- 230000004044 response Effects 0.000 description 10
- 230000021736 acetylation Effects 0.000 description 7
- 238000006640 acetylation reaction Methods 0.000 description 7
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 7
- 108010033040 Histones Proteins 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000003487 electrochemical reaction Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 102100033639 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 4
- 108090000526 Papain Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 229940055729 papain Drugs 0.000 description 4
- 235000019834 papain Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000007743 anodising Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810323247.5A CN108562738B (zh) | 2018-04-03 | 2018-04-03 | 一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810323247.5A CN108562738B (zh) | 2018-04-03 | 2018-04-03 | 一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108562738A true CN108562738A (zh) | 2018-09-21 |
CN108562738B CN108562738B (zh) | 2020-07-21 |
Family
ID=63534677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810323247.5A Active CN108562738B (zh) | 2018-04-03 | 2018-04-03 | 一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108562738B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109613093A (zh) * | 2019-01-21 | 2019-04-12 | 宁波大学 | 基于dna纳米三棱柱构建组蛋白乙酰转移酶电化学发光生物传感器及其应用 |
CN110672590A (zh) * | 2019-09-26 | 2020-01-10 | 宁波大学 | 基于电化学合成的Ru-MOF构建乙酰转移酶电化学发光传感器及其应用 |
CN110895260A (zh) * | 2019-10-14 | 2020-03-20 | 宁波大学 | 基于DNA纳米网的美杜莎式p300电化学发光传感器的制备方法及应用 |
WO2022156677A1 (zh) * | 2021-01-19 | 2022-07-28 | 中国计量科学研究院 | 基于dna四面体的复合磁性纳米材料、制备及应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072263A1 (en) * | 2002-04-19 | 2004-04-15 | Baylor College Of Medicine | Quantitative measurement of proteins using genetically-engineered glucose oxidase fusion molecules |
US20140158535A1 (en) * | 2012-12-07 | 2014-06-12 | Jonathan Javitt | Electrochemical Amperometry-Based Sensor Combined With Long-Range Radio Communication For Measurement Of Analytes |
CN105300963A (zh) * | 2015-10-22 | 2016-02-03 | 宁波大学 | 用于检测海洋致病菌的夹心式电化学发光免疫传感器的制备方法及其应用 |
KR20170085320A (ko) * | 2016-01-14 | 2017-07-24 | 가천대학교 산학협력단 | 환원된 그래핀 산화물이 증착된 ice 전극, 이의 제조방법, 상기 환원된 그래핀 산화물이 증착된 ice 전극을 기반으로 한 인슐린 센서, 및 이의 제조방법 |
CN106979964A (zh) * | 2017-02-19 | 2017-07-25 | 十堰市太和医院 | 一种用于vkorc1‑1639g>a基因多态性检测的电化学传感器制备方法 |
-
2018
- 2018-04-03 CN CN201810323247.5A patent/CN108562738B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072263A1 (en) * | 2002-04-19 | 2004-04-15 | Baylor College Of Medicine | Quantitative measurement of proteins using genetically-engineered glucose oxidase fusion molecules |
US20140158535A1 (en) * | 2012-12-07 | 2014-06-12 | Jonathan Javitt | Electrochemical Amperometry-Based Sensor Combined With Long-Range Radio Communication For Measurement Of Analytes |
CN105300963A (zh) * | 2015-10-22 | 2016-02-03 | 宁波大学 | 用于检测海洋致病菌的夹心式电化学发光免疫传感器的制备方法及其应用 |
KR20170085320A (ko) * | 2016-01-14 | 2017-07-24 | 가천대학교 산학협력단 | 환원된 그래핀 산화물이 증착된 ice 전극, 이의 제조방법, 상기 환원된 그래핀 산화물이 증착된 ice 전극을 기반으로 한 인슐린 센서, 및 이의 제조방법 |
CN106979964A (zh) * | 2017-02-19 | 2017-07-25 | 十堰市太和医院 | 一种用于vkorc1‑1639g>a基因多态性检测的电化学传感器制备方法 |
Non-Patent Citations (7)
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109613093A (zh) * | 2019-01-21 | 2019-04-12 | 宁波大学 | 基于dna纳米三棱柱构建组蛋白乙酰转移酶电化学发光生物传感器及其应用 |
CN109613093B (zh) * | 2019-01-21 | 2020-10-27 | 宁波大学 | 基于dna纳米三棱柱构建组蛋白乙酰转移酶电化学发光生物传感器及其应用 |
CN110672590A (zh) * | 2019-09-26 | 2020-01-10 | 宁波大学 | 基于电化学合成的Ru-MOF构建乙酰转移酶电化学发光传感器及其应用 |
CN110672590B (zh) * | 2019-09-26 | 2022-06-07 | 宁波大学 | 基于电化学合成的Ru-MOF构建乙酰转移酶电化学发光传感器及其应用 |
CN110895260A (zh) * | 2019-10-14 | 2020-03-20 | 宁波大学 | 基于DNA纳米网的美杜莎式p300电化学发光传感器的制备方法及应用 |
CN110895260B (zh) * | 2019-10-14 | 2022-07-15 | 宁波大学 | 基于DNA纳米网的美杜莎式p300电化学发光传感器的制备方法及应用 |
WO2022156677A1 (zh) * | 2021-01-19 | 2022-07-28 | 中国计量科学研究院 | 基于dna四面体的复合磁性纳米材料、制备及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108562738B (zh) | 2020-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108562738A (zh) | 一种检测组蛋白乙酰转移酶的电化学发光法拉第笼免疫传感器 | |
Ma et al. | Copper-mediated DNA-scaffolded silver nanocluster on–off switch for detection of pyrophosphate and alkaline phosphatase | |
Llenado et al. | Surfactants | |
AU637775B2 (en) | Electrochemiluminescent assays | |
Shi et al. | Progress on the application of electrochemiluminescence biosensor based on nanomaterials | |
US6881536B1 (en) | Particle based electrochemiluminescent assays | |
Rusling | Nanomaterials‐based electrochemical immunosensors for proteins | |
JPH0137693B2 (zh) | ||
CN104777206B (zh) | 一种检测土霉素的适体电极及其制备方法 | |
Han et al. | A chemiluminescence aptasensor for sensitive detection of carcinoembryonic antigen based on dual aptamer-conjugates biorecognition | |
CN108593751B (zh) | 一种检测组蛋白乙酰转移酶活性的电化学法拉第笼免疫传感器的构建方法及应用 | |
CN102313732A (zh) | 增强和调节化学发光反应的光发射的方法 | |
CN102352311A (zh) | 基于适体-金纳米-酶复合物的凝血酶电化学传感器检测法 | |
CN111208178B (zh) | 一种基于钴基金属有机框架物双重放大苝四羧酸信号构建电化学发光传感器的方法 | |
CN110455786B (zh) | 一种基于CeO2@SnS2促进鲁米诺电致化学发光传感器的制备方法 | |
AU677017B2 (en) | Biotinylated chemiluminescent labels, and their conjugates, assays and assay kits | |
Chang et al. | Electrochemical detection of kinase by converting homogeneous analysis into heterogeneous assay through avidin-biotin interaction | |
CN108333536B (zh) | 基于纵向弛豫时间信号读出的磁传感器及其构建方法、用途 | |
CN109444240B (zh) | 一种基于普鲁士蓝的电化学免疫传感器及基于该传感器所建立的电化学免疫传感方法和应用 | |
CN101923092A (zh) | 丝网印刷电极的癌胚抗原工作电极的制备方法 | |
Yan et al. | Biomineralization-inspired magnetic nanoflowers for sensitive miRNA detection based on exonuclease-assisted target recycling amplification | |
CN112538518B (zh) | 一种基于纳米酶检测组蛋白乙酰转移酶的方法 | |
US6159699A (en) | Enzyme linked chemiluminescent assay | |
Härmä et al. | Multiplex immunoassays on size-categorized individual beads using time-resolved fluorescence | |
Siggia et al. | Determination of Free Maleic and Phthalic Acids in Their Anhydrides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231020 Address after: Room 450, Building 2, Chuangye Building, No. 66 Yuanshi Road, High tech Zone, Ningbo City, Zhejiang Province, 315048 Patentee after: Ningbo Yingmu Biotechnology Co.,Ltd. Address before: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee before: Dragon totem Technology (Hefei) Co.,Ltd. Effective date of registration: 20231020 Address after: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee after: Dragon totem Technology (Hefei) Co.,Ltd. Address before: 315211 Ningbo University, 818 Fenghua Road, Jiangbei District, Ningbo, Zhejiang Patentee before: Ningbo University |